See more : Federal Realty Investment Trust (FRT) Income Statement Analysis – Financial Results
Complete financial analysis of Meghmani Organics Limited (MOL.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Meghmani Organics Limited, a leading company in the Agricultural Inputs industry within the Basic Materials sector.
- NanoCarrier Co., Ltd. (4571.T) Income Statement Analysis – Financial Results
- Dai-Dan Co., Ltd. (1980.T) Income Statement Analysis – Financial Results
- Golden Eagle Retail Group Limited (GDNEF) Income Statement Analysis – Financial Results
- Caterpillar Inc. (CATR.PA) Income Statement Analysis – Financial Results
- Diageo plc (DGEAF) Income Statement Analysis – Financial Results
Meghmani Organics Limited (MOL.NS)
About Meghmani Organics Limited
Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. It offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. The company also provides agrochemical products comprises insecticides, which include cypermethrin, chlorpyriphos, alpha cypermethrin, permethrin, bifenthrin, lambda-cyhalothrin, deltamethrin, profenophos, acetamiprid, emamectin benzoate, and fipronil; herbicides, such as triclopyr butoxy ethyl ester, as well as 2,4-D acid tech, sodium salt WP/SP, and EsterTech; intermediates, including cypermethric acid chloride, meta phenoxy benzaldehyde, meta phenoxy benzyl alcohol, monochloroacetic acid, high trans cypermethric acid chloride, and high cis cypermethric acid chloride; and technical and formulations that are used in crop protection, veterinary, public health, and wood protection applications. Meghmani Organics Limited was founded in 1986 and is based in Ahmedabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15.48B | 25.57B | 24.73B | 16.12B | 21.55B | 20.52B | 18.03B | 14.23B | 13.32B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 12.31B | 15.15B | 14.71B | 9.18B | 12.67B | 10.57B | 9.25B | 8.05B | 7.17B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 3.17B | 10.42B | 10.01B | 6.93B | 8.89B | 9.95B | 8.78B | 6.18B | 6.16B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 20.48% | 40.74% | 40.50% | 43.01% | 41.23% | 48.49% | 48.70% | 43.44% | 46.21% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 39.75M | 31.91M | 24.81M | 24.81M | 20.97M | 19.13M | 15.71M | 13.88M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 143.73M | 87.45M | 71.39M | 94.19M | 129.73M | 92.34M | 0.00 | 0.00 | 764.85M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 349.11M | 825.94M | 1.08B | 337.77M | 330.79M | 286.24M | 0.00 | 0.00 | 42.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 492.84M | 2.19B | 1.16B | 431.96M | 460.53M | 378.57M | 1.03B | 686.49M | 764.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 3.95B | 959.63M | 3.23M | 7.16M | 21.91M | 14.67M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.44B | 7.46B | 6.64B | 4.59B | 5.40B | 5.36B | 5.21B | 4.18B | 4.11B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost & Expenses | 16.71B | 22.61B | 21.35B | 13.77B | 18.07B | 15.93B | 14.46B | 12.22B | 11.27B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Income | 7.61M | 11.85M | 23.83M | 26.48M | 58.56M | 43.36M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 409.04M | 644.05M | 69.27M | 111.93M | 396.32M | 492.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 922.24M | 770.64M | 626.53M | 506.81M | 224.10M | 972.59M | 947.10M | 904.61M | 764.78M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 119.50M | 4.10B | 4.81B | 3.11B | 2.35B | 5.55B | 4.32B | 2.89B | 2.61B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Ratio | 0.77% | 18.34% | 18.67% | 18.30% | 22.33% | 28.34% | 23.98% | 20.28% | 19.58% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.17B | 3.92B | 3.16B | 2.34B | 3.93B | 4.84B | 3.38B | 1.98B | 1.84B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income Ratio | -7.56% | 15.33% | 12.77% | 14.53% | 18.22% | 23.60% | 18.73% | 13.92% | 13.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -41.47M | -5.73B | -4.93B | -3.63B | 3.06B | -506.96M | -120.07M | -423.58M | -379.78M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -1.21B | 3.27B | 4.09B | 2.52B | 3.59B | 4.09B | 3.26B | 1.56B | 1.46B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -7.83% | 12.81% | 16.53% | 15.62% | 16.66% | 19.91% | 18.06% | 10.95% | 10.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -151.52M | 770.47M | 1.04B | 653.22M | 700.28M | 1.13B | 877.88M | 395.52M | 351.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -1.06B | 2.38B | 3.04B | 1.86B | 2.40B | 2.51B | 1.71B | 877.04M | 825.03M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Ratio | -6.85% | 9.30% | 12.31% | 11.57% | 11.14% | 12.24% | 9.50% | 6.16% | 6.19% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -4.17 | 9.35 | 11.97 | 7.33 | 9.46 | 9.89 | 6.74 | 3.45 | 3.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -4.17 | 9.35 | 11.97 | 7.33 | 9.46 | 9.89 | 6.74 | 3.45 | 3.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 254.26M | 254.31M | 254.31M | 254.31M | 253.95M | 253.95M | 254.31M | 254.31M | 254.64M | 254.31M | 254.31M | 254.31M | 254.31M | 254.31M | 254.31M | 254.31M | 242.58M | 254.19M | 254.19M | 254.19M | 254.19M | 254.19M |
| Weighted Avg Shares Out (Dil) | 254.31M | 254.31M | 254.31M | 254.31M | 253.95M | 253.95M | 254.31M | 254.31M | 254.64M | 254.31M | 254.31M | 254.31M | 254.31M | 254.31M | 254.31M | 254.31M | 242.58M | 254.19M | 254.19M | 254.19M | 254.19M | 254.19M |
Source: https://incomestatements.info
Category: Stock Reports